Acurx Pharmaceuticals LLC (ACXP) — Defensive Interval Ratio

Latest as of December 2025: 7 days

Acurx Pharmaceuticals LLC (ACXP) has a Defensive Interval Ratio of 7 days as of December 2025. Defensive assets of $48.42K (cash $-, short-term investments $-, receivables $48.42K) cover 7 days of daily cash needs of $6.63K/day. See Acurx Pharmaceuticals LLC working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

7 days
Days of operational coverage

Defensive Assets

$48.42K
Cash + ST Investments + Receivables

Daily Cash Need

$6.63K
Current Liabilities ÷ 365

Current Liabilities

$2.42 Million
USD

Acurx Pharmaceuticals LLC Defensive Interval Ratio (2023–2025)

This chart shows how Acurx Pharmaceuticals LLC's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 7 days, meaning defensive assets of $48.42K can fund 7 days of operations without new revenue. See ACXP net asset quality score to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Acurx Pharmaceuticals LLC (2023–2025)

The table below presents the year-by-year Defensive Interval Ratio for Acurx Pharmaceuticals LLC from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ACXP stock market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 7 days $48.42K $6.63K/day $- $- ▲ +2 days
2024 6 days $51.13K $8.88K/day $- $- ▼ -10 days
2023 15 days $129.16K $8.34K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)